Body Weight and Insulin Resistance Indicators Among Children

Monika Gesek1, Danuta Zarzycka1, Arkadiusz Jędrzejewski1

  • 1Department of Pediatrics and Pediatric Nursing, Department of Integrated Nursing Care, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.

Insights

Childhood body weight is linked to insulin resistance. Overweight children show higher insulin resistance, increasing risks for metabolic disorders and long-term health issues.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Endocrinology

Background:

  • Childhood body weight is a significant factor in developing insulin resistance.
  • Insulin resistance in children poses risks for future metabolic disorders.

Purpose of the Study:

  • To investigate the relationship between body weight and insulin resistance indicators in children.
  • To analyze how body weight influences biochemical markers of insulin resistance.

Main Methods:

  • Cross-sectional study of 99 children (aged 8-14) at University Children's Hospital, Lublin (2023-2024).
  • Collected anthropometric data (weight, height, BMI), clinical data (sex, age, obesity classification), and biochemical data (glucose, insulin).
  • Assessed insulin resistance using Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and Quantitative Insulin Sensitivity Check Index (QUICKI).

Main Results:

  • Insulin resistance was diagnosed in 43.43% of the studied children.
  • Children with insulin resistance exhibited a significantly higher Body Mass Index (BMI) (P=0.001).
  • Insulin resistance was more prevalent in overweight children compared to normal or underweight children.

Conclusions:

  • Overweight and obesity in children are strongly associated with insulin resistance.
  • Early diagnosis of insulin resistance is crucial for implementing preventive strategies, like lifestyle modifications.
  • Addressing childhood insulin resistance can mitigate the risk of metabolic disorders and long-term health complications.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...